Amrit Ray
CIK: 0001924797
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 10, 2026FTRE
Fortrea Holdings Inc.
Exercise(M)Direct38.8K shares- - Jun 10, 2026FTRE
Fortrea Holdings Inc.
Award(A)DirectRestricted Stock Unit
12.9K shares- - May 14, 2026RARE
Ultragenyx Pharmaceutical Inc.
Award(A)Direct7.8K shares- - Jun 10, 2025FTRE
Fortrea Holdings Inc.
Award(A)DirectRestricted Stock Unit
38.8K shares- - May 15, 2025RARE
Ultragenyx Pharmaceutical Inc.
Award(A)Direct5.7K shares- - May 14, 2025FTRE
Fortrea Holdings Inc.
Exercise(M)Direct7.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  FTRE Fortrea Holdings Inc. | Exercise(M) | 38,817 | - | $0 | Direct |
| Jun 10, 2026 | FTRE Fortrea Holdings Inc. | Award(A) Restricted Stock Unit | 12,852 | - | - | Direct |
| May 14, 2026 |  RARE Ultragenyx Pharmaceutical Inc. | Award(A) | 7,751 | - | $0 | Direct |
| Jun 10, 2025 | FTRE Fortrea Holdings Inc. | Award(A) Restricted Stock Unit | 38,817 | - | - | Direct |
| May 15, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Award(A) | 5,740 | - | - | Direct |
| May 14, 2025 | FTRE Fortrea Holdings Inc. | Exercise(M) | 7,282 | - | - | Direct |
1-6 of 6 transactions
About Ray Amrit
Ray Amrit (SEC CIK 0001924797) files insider reports with the SEC as Director of Fortrea Holdings Inc. (FTRE) and Director of Ultragenyx Pharmaceutical Inc. (RARE).
Signal8 holds 5 ownership filings by Ray Amrit, all Form 4s, filed between May 16, 2025 and Jun 12, 2026. Those filings report 6 transactions, from May 14, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ray Amrit's filings is in DURHAM, NC.
Recent filings by Ray Amrit
- Jun 10, 2026: Option exercise of FTRE shares (Form 4, code M).
- Jun 10, 2026: Grant or award of FTRE derivative securities (Form 4, code A).
- May 14, 2026: Grant or award of RARE shares (Form 4, code A).
- Jun 10, 2025: Grant or award of FTRE derivative securities (Form 4, code A).
- May 15, 2025: Grant or award of RARE shares (Form 4, code A).
Other insiders filing for Fortrea Holdings Inc. (FTRE)
- Knoblauch Jason Fredrick, Chief Financial Officer
- Russell Carrie Elizabeth, Interim CAO
- Morais Mark A., Chief Operating Officer
- Thakral Anshul, Chief Executive Officer
- Smith David Ross, Interim CFO
- SANDERS MACHELLE, Director